The complexity of developing and manufacturing GMP peptides can often be a significant barrier to researchers. Fortunately, Contract Development and Manufacturing Organizations (CDMOs) have emerged as valuable partners in this industry. With specialized expertise and state-of-the-art facilities, CDMOs can expedite the development process, enabling